|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
decreases expression multiple interactions |
EXP |
Letrozole results in decreased expression of ADIPOQ protein Spironolactone inhibits the reaction [Letrozole results in decreased expression of ADIPOQ protein] |
CTD |
PMID:33359182 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adm |
adrenomedullin |
increases expression multiple interactions |
EXP |
Letrozole results in increased expression of ADM protein ADM protein inhibits the reaction [Letrozole results in decreased expression of AKT1 mRNA]; ADM protein inhibits the reaction [Letrozole results in decreased expression of BCL2 protein]; ADM protein inhibits the reaction [Letrozole results in decreased expression of FSHB protein]; ADM protein inhibits the reaction [Letrozole results in decreased expression of PIK3CG mRNA]; ADM protein inhibits the reaction [Letrozole results in decreased expression of PPARG mRNA]; ADM protein inhibits the reaction [Letrozole results in increased expression of ATF6 mRNA]; ADM protein inhibits the reaction [Letrozole results in increased expression of BAX protein]; ADM protein inhibits the reaction [Letrozole results in increased expression of CCN2 protein]; ADM protein inhibits the reaction [Letrozole results in increased expression of DDIT3 mRNA]; ADM protein inhibits the reaction [Letrozole results in increased expression of IL6 protein]; ADM protein inhibits the reaction [Letrozole results in increased expression of INS1 protein]; ADM protein inhibits the reaction [Letrozole results in increased expression of TGFB1 protein]; ADM protein inhibits the reaction [Letrozole results in increased expression of TNF protein]; ADM protein inhibits the reaction [Letrozole results in increased expression of XBP1 mRNA]; ADM protein promotes the reaction [Letrozole results in increased expression of ADM protein] |
CTD |
PMID:33491863 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases expression multiple interactions |
EXP |
Letrozole results in decreased expression of AKT1 mRNA ADM protein inhibits the reaction [Letrozole results in decreased expression of AKT1 mRNA] |
CTD |
PMID:33491863 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Angpt2 |
angiopoietin 2 |
multiple interactions |
ISO |
[letrozole results in decreased abundance of Estradiol] which results in decreased expression of ANGPT2 mRNA |
CTD |
PMID:19620711 |
|
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:71,088,364...71,138,804
|
|
G |
Angpt4 |
angiopoietin 4 |
multiple interactions |
ISO |
[letrozole results in decreased abundance of Estradiol] which results in decreased expression of ANGPT4 mRNA |
CTD |
PMID:19620711 |
|
NCBI chr 3:140,420,389...140,454,213
Ensembl chr 3:140,420,389...140,453,583
|
|
G |
Ar |
androgen receptor |
multiple interactions decreases expression |
ISO |
diacerein inhibits the reaction [Letrozole results in decreased expression of AR mRNA] |
CTD |
PMID:37030623 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atf6 |
activating transcription factor 6 |
increases expression multiple interactions |
EXP |
Letrozole results in increased expression of ATF6 mRNA ADM protein inhibits the reaction [Letrozole results in increased expression of ATF6 mRNA] |
CTD |
PMID:33491863 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP |
Letrozole results in increased expression of BAX protein ADM protein inhibits the reaction [Letrozole results in increased expression of BAX protein] |
CTD |
PMID:33491863 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
EXP |
ADM protein inhibits the reaction [Letrozole results in decreased expression of BCL2 protein] |
CTD |
PMID:33491863 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
multiple interactions |
ISO |
[letrozole results in decreased abundance of Estradiol] which results in decreased expression of BMP2 mRNA |
CTD |
PMID:19620711 |
|
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Cat |
catalase |
decreases activity multiple interactions |
ISO |
Letrozole results in decreased activity of CAT protein diacerein inhibits the reaction [Letrozole results in decreased activity of CAT protein] |
CTD |
PMID:37030623 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression multiple interactions |
EXP |
Letrozole results in increased expression of CCN2 protein ADM protein inhibits the reaction [Letrozole results in increased expression of CCN2 protein] |
CTD |
PMID:33491863 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression |
ISO |
[Letrozole co-treated with Everolimus] results in decreased expression of CCND1 protein; [Sirolimus co-treated with Letrozole] results in decreased expression of CCND1 protein; [Sorafenib co-treated with Letrozole] results in decreased expression of CCND1 protein letrozole results in decreased expression of CCND1 protein |
CTD |
PMID:16033851 PMID:20054642 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
multiple interactions decreases expression |
ISO |
[letrozole co-treated with Everolimus] results in decreased expression of CCND2 protein letrozole results in decreased expression of CCND2 protein |
CTD |
PMID:16033851 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
letrozole results in increased expression of CDKN1A protein |
CTD |
PMID:20054642 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
[Oleic Acid co-treated with letrozole] affects the localization of CYCS protein; [Olive Oil co-treated with letrozole] affects the localization of CYCS protein |
CTD |
PMID:24161488 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions decreases expression |
ISO |
diacerein inhibits the reaction [Letrozole results in decreased expression of CYP11A1 mRNA] |
CTD |
PMID:37030623 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
increases expression multiple interactions |
EXP ISO |
Letrozole results in increased expression of CYP17A1 mRNA Metformin inhibits the reaction [Letrozole results in increased expression of CYP17A1 mRNA]; N(1)-methylnicotinamide inhibits the reaction [Letrozole results in increased expression of CYP17A1 mRNA]; Niacinamide inhibits the reaction [Letrozole results in increased expression of CYP17A1 mRNA] diacerein inhibits the reaction [Letrozole results in increased expression of CYP17A1 mRNA] |
CTD |
PMID:32298659 PMID:37030623 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions decreases activity increases activity decreases expression |
ISO EXP |
Letrozole inhibits the reaction [[sodium arsenite results in increased activity of CYP19A1 protein] which results in increased abundance of Estradiol]; Letrozole inhibits the reaction [sodium arsenite results in increased activity of CYP19A1 protein]; Letrozole inhibits the reaction [sodium arsenite results in increased expression of CYP19A1 mRNA] Letrozole results in decreased activity of CYP19A1 protein letrozole results in increased activity of CYP19A1 protein letrozole results in decreased activity of CYP19A1 protein letrozole binds to and results in decreased activity of CYP19A1 protein Letrozole results in decreased expression of CYP19A1 mRNA diacerein inhibits the reaction [Letrozole results in decreased expression of CYP19A1 mRNA] |
CTD |
PMID:15837728 PMID:15909811 PMID:15967659 PMID:16009161 PMID:16013988 PMID:16023854 PMID:16033851 PMID:16034487 PMID:16046582 PMID:16054421 PMID:16480277 PMID:17145897 PMID:20087668 PMID:21341743 PMID:24068038 PMID:24496634 PMID:24902786 PMID:29501854 PMID:30817981 PMID:32197950 PMID:37030623 More...
|
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases oxidation |
ISO |
CYP3A4 protein results in increased oxidation of Letrozole |
CTD |
PMID:19845430 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases activity |
ISO |
letrozole results in decreased activity of CYP51A1 protein |
CTD |
PMID:16989930 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
EXP |
Letrozole results in increased expression of DDIT3 mRNA ADM protein inhibits the reaction [Letrozole results in increased expression of DDIT3 mRNA] |
CTD |
PMID:33491863 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
increases expression |
ISO |
letrozole results in increased expression of DKK1 mRNA |
CTD |
PMID:21851939 |
|
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions |
ISO |
[letrozole co-treated with Everolimus] results in increased phosphorylation of and results in decreased activity of EIF4EBP1 protein; letrozole results in increased phosphorylation of and results in decreased activity of EIF4EBP1 protein |
CTD |
PMID:16033851 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
increases expression |
ISO |
letrozole results in increased expression of ELK1 protein |
CTD |
PMID:15967659 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
multiple interactions |
ISO |
[letrozole results in decreased abundance of Estradiol] which results in decreased expression of EPAS1 mRNA |
CTD |
PMID:19620711 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression multiple interactions |
ISO |
Letrozole results in decreased expression of ESR1 mRNA diacerein inhibits the reaction [Letrozole results in decreased expression of ESR1 mRNA] |
CTD |
PMID:37030623 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Fgf22 |
fibroblast growth factor 22 |
increases expression |
ISO |
letrozole results in increased expression of FGF22 mRNA |
CTD |
PMID:21851939 |
|
NCBI chr 7:9,947,632...9,956,918
Ensembl chr 7:9,948,071...9,950,486
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
increases expression multiple interactions decreases secretion decreases expression |
ISO EXP |
letrozole results in increased expression of FSHB protein ADM protein inhibits the reaction [Letrozole results in decreased expression of FSHB protein]; Spironolactone inhibits the reaction [Letrozole results in decreased secretion of FSHB protein] diacerein inhibits the reaction [Letrozole results in decreased expression of FSHB protein] |
CTD |
PMID:15123030 PMID:31295448 PMID:33491863 PMID:37030623 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fshr |
follicle stimulating hormone receptor |
multiple interactions decreases expression |
ISO |
diacerein inhibits the reaction [Letrozole results in decreased expression of FSHR mRNA] |
CTD |
PMID:37030623 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
decreases expression |
ISO |
letrozole results in decreased expression of GJA1 protein |
CTD |
PMID:29180066 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Grb2 |
growth factor receptor bound protein 2 |
increases expression |
ISO |
letrozole results in increased expression of GRB2 protein |
CTD |
PMID:15967659 |
|
NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases expression multiple interactions |
EXP |
Letrozole results in decreased expression of GSR protein Spironolactone inhibits the reaction [Letrozole results in decreased expression of GSR protein] |
CTD |
PMID:31295448 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hmox1 |
heme oxygenase 1 |
decreases expression multiple interactions |
EXP |
letrozole results in decreased expression of HMOX1 protein indole-3-carbinol inhibits the reaction [Letrozole results in decreased expression of HMOX1 protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [Letrozole results in decreased expression of HMOX1 protein]]; Linagliptin inhibits the reaction [Letrozole results in decreased expression of HMOX1 protein]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [Letrozole results in decreased expression of HMOX1 protein]] |
CTD |
PMID:28619389 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Il10 |
interleukin 10 |
increases expression multiple interactions |
EXP |
letrozole results in increased expression of IL10 protein indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of IL10 protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [Letrozole results in increased expression of IL10 protein]]; Linagliptin inhibits the reaction [Letrozole results in increased expression of IL10 protein]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of IL10 protein]] |
CTD |
PMID:28619389 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
EXP |
Letrozole results in increased expression of IL6 protein ADM protein inhibits the reaction [Letrozole results in increased expression of IL6 protein]; Spironolactone inhibits the reaction [Letrozole results in increased expression of IL6 protein] |
CTD |
PMID:33359182 PMID:33491863 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions increases expression |
EXP ISO |
ADM protein inhibits the reaction [Letrozole results in increased expression of INS1 protein]; indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of INS1 protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [Letrozole results in increased expression of INS1 protein]]; Linagliptin inhibits the reaction [Letrozole results in increased expression of INS1 protein]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of INS1 protein]]; Spironolactone inhibits the reaction [Letrozole results in increased expression of INS1 protein] diacerein inhibits the reaction [Letrozole results in increased expression of INS1 protein] |
CTD |
PMID:28619389 PMID:33359182 PMID:33491863 PMID:37030623 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Kitlg |
KIT ligand |
multiple interactions decreases expression |
ISO |
diacerein inhibits the reaction [Letrozole results in decreased expression of KITL mRNA] |
CTD |
PMID:37030623 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Lhb |
luteinizing hormone subunit beta |
increases expression multiple interactions increases secretion |
ISO EXP |
letrozole results in increased expression of LHB protein Letrozole results in increased expression of LHB protein indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of LHB protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [Letrozole results in increased expression of LHB protein]]; LHB protein inhibits the reaction [Letrozole results in increased expression of LHB protein]; Linagliptin inhibits the reaction [Letrozole results in increased expression of LHB protein]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of LHB protein]]; Metformin inhibits the reaction [Letrozole results in increased secretion of LHB protein]; N(1)-methylnicotinamide inhibits the reaction [Letrozole results in increased secretion of LHB protein]; Niacinamide inhibits the reaction [Letrozole results in increased secretion of LHB protein]; Spironolactone inhibits the reaction [Letrozole results in increased secretion of LHB protein] diacerein inhibits the reaction [Letrozole results in increased expression of LHB protein] |
CTD |
PMID:15123030 PMID:16046582 PMID:28619389 PMID:31295448 PMID:32298659 PMID:33491863 PMID:37030623 More...
|
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
multiple interactions decreases expression |
ISO |
diacerein inhibits the reaction [Letrozole results in decreased expression of LHR mRNA] |
CTD |
PMID:37030623 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
increases expression |
ISO |
letrozole results in increased expression of LIF mRNA; letrozole results in increased expression of LIF protein |
CTD |
PMID:21851939 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Lifr |
LIF receptor subunit alpha |
increases expression |
ISO |
letrozole results in increased expression of LIFR mRNA |
CTD |
PMID:21851939 |
|
NCBI chr 2:56,224,393...56,292,988
Ensembl chr 2:56,250,120...56,286,699
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
increases expression |
ISO |
letrozole results in increased expression of MAP2K1 protein |
CTD |
PMID:15967659 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
increases expression |
ISO |
letrozole results in increased expression of MAP2K2 protein |
CTD |
PMID:15967659 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
letrozole results in increased expression of and results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:15967659 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
letrozole results in increased expression of and results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:15967659 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression |
ISO |
letrozole results in decreased expression of MKI67 protein |
CTD |
PMID:16002280 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
letrozole inhibits the reaction [sodium arsenite results in increased activity of and results in increased secretion of MMP2 protein] |
CTD |
PMID:24068038 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
letrozole inhibits the reaction [sodium arsenite results in increased activity of and results in increased secretion of MMP9 protein] |
CTD |
PMID:24068038 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
[Letrozole co-treated with Everolimus] inhibits the reaction [Androstenedione affects the activity of MTOR protein]; Letrozole inhibits the reaction [Androstenedione affects the activity of MTOR protein]; Letrozole inhibits the reaction [Estradiol affects the activity of MTOR protein] |
CTD |
PMID:16033851 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
[Sirolimus co-treated with letrozole] results in decreased expression of MYC protein; [sorafenib co-treated with letrozole] results in decreased expression of MYC protein |
CTD |
PMID:20054642 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
multiple interactions increases expression |
EXP |
Metformin inhibits the reaction [Letrozole results in increased expression of NAMPT mRNA]; N(1)-methylnicotinamide inhibits the reaction [Letrozole results in increased expression of NAMPT mRNA]; Niacinamide inhibits the reaction [Letrozole results in increased expression of NAMPT mRNA] |
CTD |
PMID:32298659 |
|
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions decreases expression |
EXP |
indole-3-carbinol inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein]]; Linagliptin inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein]] |
CTD |
PMID:28619389 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
multiple interactions |
ISO |
[letrozole results in decreased abundance of Estradiol] which results in decreased expression of PECAM1 protein |
CTD |
PMID:19620711 |
|
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pgr |
progesterone receptor |
decreases expression |
ISO |
letrozole results in decreased expression of PGR protein |
CTD |
PMID:16002280 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
decreases expression multiple interactions |
EXP |
Letrozole results in decreased expression of PIK3CG mRNA ADM protein inhibits the reaction [Letrozole results in decreased expression of PIK3CG mRNA] |
CTD |
PMID:33491863 |
|
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions decreases expression |
EXP |
ADM protein inhibits the reaction [Letrozole results in decreased expression of PPARG mRNA] |
CTD |
PMID:33491863 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prl |
prolactin |
multiple interactions increases expression |
EXP |
Spironolactone inhibits the reaction [Letrozole results in increased expression of PRL protein] |
CTD |
PMID:33359182 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
increases expression |
ISO |
letrozole results in increased expression of RAF1 protein |
CTD |
PMID:15967659 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
[letrozole co-treated with Everolimus] results in decreased phosphorylation of and affects the activity of RB1 protein; [Sirolimus co-treated with letrozole] results in decreased expression of RB1 protein; [sorafenib co-treated with letrozole] results in decreased expression of RB1 protein; letrozole results in decreased phosphorylation of and affects the activity of RB1 protein |
CTD |
PMID:16033851 PMID:20054642 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions affects localization |
EXP |
indole-3-carbinol inhibits the reaction [letrozole affects the localization of RELA protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [letrozole affects the localization of RELA protein]]; Linagliptin inhibits the reaction [letrozole affects the localization of RELA protein]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [letrozole affects the localization of RELA protein]] |
CTD |
PMID:28619389 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Retn |
resistin |
increases expression multiple interactions |
EXP |
Letrozole results in increased expression of RETN mRNA Metformin inhibits the reaction [Letrozole results in increased expression of RETN mRNA]; N(1)-methylnicotinamide inhibits the reaction [Letrozole results in increased expression of RETN mRNA] |
CTD |
PMID:32298659 |
|
NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
|
|
G |
Rps6 |
ribosomal protein S6 |
multiple interactions decreases phosphorylation |
ISO |
[letrozole co-treated with Everolimus] results in decreased phosphorylation of RPS6 protein letrozole results in decreased phosphorylation of RPS6 protein |
CTD |
PMID:16033851 |
|
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
|
|
G |
Rps6ka1 |
ribosomal protein S6 kinase A1 |
multiple interactions |
ISO |
letrozole results in increased expression of and results in increased phosphorylation of RPS6KA1 protein |
CTD |
PMID:15967659 |
|
NCBI chr 5:146,079,018...146,118,272
Ensembl chr 5:146,079,021...146,118,272
|
|
G |
Shc1 |
SHC adaptor protein 1 |
increases expression |
ISO |
letrozole results in increased expression of SHC1 protein |
CTD |
PMID:15967659 |
|
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
letrozole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions decreases expression |
EXP |
Metformin inhibits the reaction [Letrozole results in decreased expression of SLC2A4 mRNA]; Niacinamide inhibits the reaction [Letrozole results in decreased expression of SLC2A4 mRNA] |
CTD |
PMID:32298659 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Tert |
telomerase reverse transcriptase |
multiple interactions |
ISO |
letrozole inhibits the reaction [Metribolone results in increased activity of TERT protein] |
CTD |
PMID:19561322 |
|
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions increases expression |
EXP |
ADM protein inhibits the reaction [Letrozole results in increased expression of TGFB1 protein]; indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of TGFB1 protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [Letrozole results in increased expression of TGFB1 protein]]; Linagliptin inhibits the reaction [Letrozole results in increased expression of TGFB1 protein]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of TGFB1 protein]] |
CTD |
PMID:28619389 PMID:33491863 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
increases expression multiple interactions |
EXP |
Letrozole results in increased expression of TNF protein ADM protein inhibits the reaction [Letrozole results in increased expression of TNF protein]; indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of TNF protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [Letrozole results in increased expression of TNF protein]]; Linagliptin inhibits the reaction [Letrozole results in increased expression of TNF protein]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of TNF protein]]; Spironolactone inhibits the reaction [Letrozole results in increased expression of TNF protein] |
CTD |
PMID:28619389 PMID:33359182 PMID:33491863 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions increases expression |
ISO |
diacerein inhibits the reaction [Letrozole results in increased expression of VEGFA protein] |
CTD |
PMID:37030623 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Xbp1 |
X-box binding protein 1 |
multiple interactions increases expression |
EXP |
ADM protein inhibits the reaction [Letrozole results in increased expression of XBP1 mRNA] |
CTD |
PMID:33491863 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|